Skip to main content

Home/ health information/ Group items matching "file" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
1More

File Your Company Accounts on Time:Personal liability - 0 views

  •  
    All companies must send their accounts to Companies House each year. Recent evidence suggests that UK companies are increasingly struggling to file their accounts on time, with around 213,000 private companies reportedly missing their deadline in 2019-2020, resulting in over £93 million of penalties being issued. Over a fifth of companies that filed their accounts late that year had also filed late in the previous year. Under the Companies Act 2006 ("the Act"), the deadline for private companies to file their annual accounts is nine months from the end of the accounting reference period. There are slightly different rules for filing your first set of annual accounts and if these cover a period of more than 12 months, you must deliver them to Companies House within 21 months of the date of incorporation or 3 months from the accounting reference date, whichever is longer. Not filing your accounts at Companies House in a timely manner is also a criminal offence (under section 451 of the Act) and directors can be personally fined in the criminal courts. It is likely to come as a shock to most company directors who receive a summons to attend the Magistrates' Court in Cardiff for a criminal prosecution, particularly directors in larger pharmacy companies where directors are often detached from the preparation of accounts and senior financial staff and accountants are instructed to take care of such matters.
1More

VAT penalties regime UK : New updation 2023 - 0 views

  •  
    The VAT penalties regime has had substantial changes with effect from 01 January 2023 and it is important for community pharmacy business owners to take note as this is a crucial cash inflow for most. Below we explore the changes that will impact all VAT registered community pharmacy businesses. Old regime Prior to 01 January 2023, VAT registered businesses that failed to file their VAT returns or pay any VAT liabilities would be subject to the default surcharge regime. There would be no surcharge for NIL or repayment VAT returns which would apply to most community pharmacy businesses. New regime For VAT periods starting on or after 01 January 2023, the default surcharge will be replaced by a new VAT penalties and interest regime if you submit your VAT returns late or pay your VAT liability late. If you pay your VAT monthly or quarterly, the deadline for filing your VAT return and paying any VAT liabilities is one calendar month and 7 days after the end of the respective period. For example, if you are filing the VAT return for the month or quarter ended 30 June 2022, the deadline for filing will be 07 August 2022. The liability must also be paid and cleared by that date.
1More

Novavax full approval of Covid vaccine later this year - 0 views

  •  
    American biotechnology company Novavax said on Monday (February 28) it would pursue full approval of its Covid-19 vaccine in the second half of this year and forecast total revenue of between $4 billion and $5 billion for 2022. "We expect to gain additional authorizations where we have already filed, including in the US. We will pursue full approval of our vaccine including filing our BLA (biologics license application), in the second half of 2022," CEO Stanley Erck said during a post-earnings call. Novavax late last month filed for emergency use authorization of the shot in U.S. adults, a much-awaited step following months of struggles with development and manufacturing problems. Novavax said it has completed delivery of around nine million vaccine doses to Indonesia, 6 million to Australia and two million to South Korea and expects to supply 69 million doses to Europe in the first half of this year.
2More

Kẹp file, cặp đựng tài liệu mẫu mã đẹp giá rẻ tại TPHCM - 0 views

  •  
    Chuyên bán sỉ và lẻ các loại kẹp file, cặp đựng tài liệu nhiều ngăn bằng nhựa mẫu mã đẹp, dễ thương theo phong cách Hàn Quốc, đảm bảo giá rẻ nhất tại TPHCM
  •  
    Chuyên bán sỉ và lẻ các loại kẹp file, cặp đựng tài liệu nhiều ngăn bằng nhựa mẫu mã đẹp, dễ thương theo phong cách Hàn Quốc, đảm bảo giá rẻ nhất tại TPHCM
1More

Timely Medical Malpractice Claims: Why You Shouldn't Delay - 0 views

  •  
    When faced with the unfortunate situation of medical malpractice, it's understandable that you may feel overwhelmed and uncertain about the next steps. One crucial aspect that often gets overlooked in the turmoil is the importance of timely filing a medical malpractice claim. Delaying this process can have significant negative consequences on your ability to secure justice and compensation. Here's why you shouldn't delay in filing a medical malpractice claim. A Crucial Step in Seeking Justice When faced with legal challenges, finding the right lawyer is paramount. Your choice of legal representation can significantly impact the outcome of your case and your overall experience throughout the legal process. Begin by identifying lawyers with expertise in your specific legal issue, whether it's personal injury, family law, or business disputes. Conduct thorough research, read client reviews, and seek recommendations from trusted sources to narrow down your options. Meet with potential attorneys for consultations to assess their experience, communication style, and commitment to your case. Whether you are looking for a Scranton Medical Malpractice Lawyer or in any other place, look for a lawyer who not only has the necessary skills and knowledge but also demonstrates empathy, transparency, and a genuine dedication to advocating for your rights. By investing time and effort into finding the right lawyer, you set the foundation for a strong legal strategy and increase your chances of a favorable resolution.
1More

Kẹp file, cặp đựng tài liệu mẫu mã đẹp giá rẻ tại TPHCM - 0 views

  •  
    Chuyên bán sỉ và lẻ các loại kẹp file, cặp đựng tài liệu nhiều ngăn bằng nhựa mẫu mã đẹp, dễ thương theo phong cách Hàn Quốc, đảm bảo giá rẻ nhất tại TPHCM
1More

Computer Science: Computer hardware - 0 views

  •  
    Computer Science Tuesday, April 25, 2023 Computer hardware Computer hardware is the physical components that make up a computer system. It includes everything from the central processing unit (CPU) to the monitor, keyboard, and mouse. Understanding the different types of hardware and how they work together is essential for anyone who works with computers. In this article, we will explore the various components of computer hardware, including internal and external components, and the peripherals that connect to them. We will also discuss the importance of hardware maintenance, the latest advancements in computer technology, and factors to consider when choosing the right hardware for your needs. Whether you are a computer technician, a gamer, or simply someone who uses a computer for everyday tasks, this article will help you better understand the world of computer hardware. Introduction to Computer Hardware Computer hardware refers to the physical components that make up a computer system. It includes everything from the processor and memory to input/output devices such as the keyboard and monitor. In this article, we will explore the different types of computer hardware and their functions. What is Computer Hardware Computer hardware refers to the physical components of a computer system. It includes all the components that can be touched, seen, and used to interact with a computer, such as the monitor, keyboard, and mouse. Hardware is different from computer software, which refers to the programs and applications that run on a computer system. History of Computer Hardware The history of computer hardware dates back to the 1820s when Charles Babbage, an English mathematician, and inventor, designed the first analytical engine, which was considered to be the first mechanical computer. With time, more complex electronic computers were developed, including the first Intel microprocessor in 1971. Since then, computer hardware has continued to evolve, becoming
1More

Pfizer, BioNTech countersue Moderna over vaccine patents - 0 views

  •  
    Pfizer and its German partner, BioNTech, fired back at Moderna on Monday in a patent lawsuit over their rival Covid-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the Covid-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany. All three companies are also embroiled in US patent disputes with other companies over the vaccines. A Pfizer spokesperson said the company and BioNTech are confident in their intellectual property and will "vigorously defend" against Moderna's claims. Moderna did not immediately respond to a request for comment on the Monday filing.
1More

Justin Bieber and Usher Cleared "Somebody to Love" Case| Locality News - 0 views

  •  
    Pop sensation Justin Bieber and Usher within the clear when decide laid-off a replica case filed against them over the song 'Somebody to love.'
1More

Pluristem files orphan drug application to US FDA for preeclampsia - 0 views

  •  
    PBR Staff Writer Published 21 February 2014 Israel-based Pluristem Therapeutics has submitted its application to the US Food and Drug Administration seeking Orphan Drug Designation for its PLacental eXpanded (PLX-PAD) cells for the treatment of severe preeclampsia.
1More

KYTHERA files NDA for ATX-101 to reduce unwanted submental fat - 1 views

  •  
    US-based KYTHERA Biopharmaceuticals has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ATX-101 (deoxycholic acid) as an injectable treatment for the reduction of submental fat, which commonly presents as a double chin.
1More

Overland Optical Family Eye Care medical & vision insurance plans - 0 views

  •  
    Overland Optical Family Eye Care and/or our doctors are providers on virtually all medical and vision insurance plans. We want to help you receive the most out of your insurance benefits, which is why we will gladly file your insurance claim for you if we have been provided with all of your insurance information.
1More

Pedi Spin Price in Pakistan,Lahore,Karachi,Islamabad,Quetta | Online Shop In All Over P... - 0 views

  •  
    PRODUCT DESCRIPTION PEDI SPIN CALLUS REMOVER IN PAKISTAN OpenTeleShop Pedi Spin fast and simple and gentle way to enjoy a beautiful smooth soles. Pedi Spin in Pakistan OpenTeleShop electronic foot file removes the fabric, patches of raw skin Dead effort from your heel, and toes, soles, leaving them soft and gorgeous salon.Pedi Spin Callus Remover easy to use and is completely painless, and are caught in the trap of all the shavings storage so theres no mess. Pedi Spin offers two different speeds to help you remove the light and heavy callouses.Safe And 100% Working Products For Women Beauty. PEDI SPIN CALLUS REMOVER FEATURES 1-A well established brand 2-Pedicure Home Electronic System 3-Removes dead skin and tissue 4-Papers presented at a silky smooth and soft 5-Totally painless and gentle on your feet 6-Offers high and low speed settings 7-Comfortable and easy to use 8-Panel deposit to remove tissue PEDI SPIN CALLUS REMOVER PRICE IN PAKISTAN:2000/PKR OpenTeleShop offers a Best Pedi Spin Callus Remover Price in Pakistan 1999/- Home Delivery, Payment on Delivery, Available all Cities of Pakistan. Like Karachi, Hyderabad, Lahore, Islamabad, Okara, Sialkot, Gujranwala, Faisalabad, Peshawar, Quetta, Multan, jhelum, Wah Cantt, Gujrat, Rawalpindi and All Over the Pakistan.
1More

File:3 Most Important Steps To Redo Extractions Due To damaged Dentures.jpg - Wikimedia... - 0 views

  •  
    You should know the important steps to redo tooth extraction
1More

&ME- India's First Menstrual drink gets a backing of $1 million - Gossip Ki Galliyan - 0 views

  •  
    &Me, a Bangalore headquartered startup, is the proud seller of India's first menstrual drink. The brand is founded by Ankur Goyal, an alumnus of Stanford business school. Matrix partners and Sauce.vc. together are set to invest $ 1 million (INR 7 crores approx.) in &Me. RoC filings show that they have invested in new shares of &Me's parent company called Merhaki Foods and Nutrition.
1More

Telemedicine: The Positive & Negative Impacts | Health Beyond Insurance - 0 views

  •  
    The COVID-19 pandemic has made virtual care a normal thing in the healthcare industry. More than 41 million telehealth claims were filed between April and July 2020. Here are the impacts, both positive and negative, of telemedicine.
1More

Pharmacists Rights at Risk:PDA TUPE with LloydsPharmacy - 0 views

  •  
    The Pharmacists' Defence Association (PDA) has begun conciliation with 86 pharmacy companies to safeguard the interests of former LloydsPharmacy pharmacists. The Advisory, Conciliation and Arbitration Service (Acas), a government agency, serves as a mediator between companies and employees to resolve disputes. If the ongoing mediation prove unsuccessful, individual employees retain the option to file claims in the employment tribunal, the PDA has said. The ongoing dispute centres around employers potentially failing to conduct the required consultation under the Transfer of Undertakings (Protection of Employment) regulations (TUPE) with employees and their representatives during employee transfers, the PDA said. The TUPE legislation, known for its complexity and technical nature, applies when a section of the company, like a pharmacy sold as an asset using standard disposal, undergoes a transfer. According to NHS England's recent pharmaceutical list, LloydsPharmacy has either sold or shuttered 461 branches since September 2022. According to NHSE data, as of June 30, the pharmacy chain operates approximately 512 pharmacies in England. This positions it as the third-largest chain after Boots UK and Well Pharmacy.
1More

Zantac : Drugmakers shares stabilise after litigation slump - 0 views

  •  
    Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday (Aug 12) after the companies said that nothing material had changed regarding US litigation focused on heartburn drug Zantac. The companies' share prices had fallen sharply last week on investor concern about the litigation over potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020. More than 2,000 Zantac-related legal cases have been filed in the United States, analysts say, with the first trial beginning this month. The prospect of impending Zantac litigation is not new. Among other disclosures, recently listed Haleon had highlighted the risk of such lawsuits in its prospectus. GSK, Sanofi, Pfizer and Haleon have lost a combined $39 billion from their market value over the past week in the absence of any other particular catalyst, according to Barclays analysts.
1More

New GSK raises 2022 forecast for second time in four months - 0 views

  •  
    New GSK raised its 2022 forecast for the second time this year, after third-quarter earnings and sales topped estimates, continuing its strong start as a standalone prescription medicine and vaccine business since carving out its consumer health division Haleon. After years of underperformance relative to its peers and missing out on the lucrative market for the first set of COVID-19 vaccines, GSK has delivered a string of strong results. The latest is led by a record quarter for its blockbuster shingles vaccine Shingrix and higher-than-expected revenue from its COVID therapy, Xevudy. Having survived a revolt by activist investors Elliott and Bluebell last year, GSK's prospects have been boosted by clinical trial success, though concerns remain around U.S. litigation over heartburn drug Zantac. Thousands of lawsuits have been filed in the United States against a raft of drugmakers over allegations the heartburn drug contains a probable carcinogen.
1More

MedAdvisor Invests $1.9 Mn in Charac | Pharmacy Partnership - 0 views

  •  
    MedAdvisor will be investing $1.9 million (£1 million) into UK-based pharmacy dispensary app Charac, while securing a 7.4 per cent shareholding in the later company. Under this new agreement, MedAdvisor CEO Rick Ratliff will become a Non-Executive Director (NED) on the board of Charac. Both MedAdvisor and Charac provide digital medication adherence solutions that allow customers to file prescription orders to their local pharmacy through mobile apps. The investment is seen as part of MedAdvisor's cost saving strategy, as the Australian company has decided to discontinue its UK operations, and transfer its existing pharmacy relationships to Charac.
1 - 20 of 28 Next ›
Showing 20 items per page